All data are based on the daily closing price as of October 8, 2025
j

Johnson Chemical Pharmaceutical Works

4747.TWO
2.29 USD
-0.01
-0.43%

Overview

Last close
2.29 usd
Market cap
103.00M usd
52 week high
2.65 usd
52 week low
1.93 usd
Target price
N/A usd

Valuation

P/E
38.7293
Forward P/E
N/A
Price/Sales
5.4045
Price/Book Value
1.9167
Enterprise Value
73.71M usd
EV/Revenue
3.8675
EV/EBITDA
17.3436

Key financials

Revenue TTM
19.06M usd
Gross Profit TTM
7.72M usd
EBITDA TTM
3.75M usd
Earnings per Share
0.06 usd
Dividend
0.06 usd
Total assets
68.46M usd
Net debt
N/A usd

About

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials, and products in Taiwan. The company offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamin, anti-inflammatory, cough and cold, pain reliever, etc. It provides its products in the solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. Johnson Chemical Pharmaceutical Works Co., Ltd. was founded in 1959 and is based in New Taipei City, Taiwan.
  • Symbol
    4747.TWO
  • Exchange
    TWO
  • Isin
    TW0004747001
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. P. H. Huang
  • Headquarter
    New Taipei City
  • Web site
    https://www.jcpjohnson.com.tw
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top